The Toxin combines style and critical functions in one complete package. The Toxin is DOT/ECE 22.05 approved - a durable and lightweight polymer shell combined with a well ventilated dual-stage EPS. The Toxin is further enhanced with an integrated MIPS Multi-directional Impact Protection System.
- Construction:
- MIPS Brain Protection System: helmet-integrated, low-friction layer designed to reduce rotational motion transferred to the brain from angled impacts.
- Durable and lightweight polymer shell.
- Dual-density EPS (expanded polystyrene) liner.
- Custom rubber trim with integrated nose guard.
- Lightweight machined aluminum visor screws.
- Stainless steel rivets and D-rings.
- Comfort / Liner:
- Removable and washable comfort liner and cheek pads absorb sweat while providing ventilation.
- Ventilation:
- All FLY helmets have TFV (True Functional Ventilation): When in motion, air is forced through multiple air intake vents, then passed through aligned vent channels in the EPS and exits out multiple rear exhaust vents.
- High-flow mouthpiece is replaceable.
- Included Accessories:
- Standard:
- Youth model.
MIPS:
MIPS is an advanced and efficient brain protection system that provides a secure environment for riders of all kinds. MIPS industry-leading technology deals with "rotational violence" which is found to be the leading cause of concussion and even more severe brain injuries. It mimics the brain's own protection system.
When the head hits the ground at an angle, the brain slides along a membrane on the inner surface of the skull, which reduces the rotational forces transmitted to the brain. The MIPS yellow Low Friction Layer (LFL) sits between the helmet's EPS and the liner. At impact there is a movement, independent of direction, between MIPS and the liner that substantially reduces the rotational force to the brain.
MIPS does not interfere with a helmet's existing safety property, performance or design, adding minimal weight and less than 1 mm in thickness. It's based on more than 15 years of R&D at the Royal Institute of Technology and The Karolinska University Hospital in Stockholm, Sweden.
